Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- Joint Venture, Subsidiary
- Established
- 1997-04-16
- Employees
- -
- Market Cap
- -
- Website
- http://www.cttq.com
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT02029209
- Locations
- 🇨🇳
20th Floor, Block C, Lake Road, Hexi District, Tianjin Medical University Cancer Institute and Hospital ., Tianjin, Tianjin, China
Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
- First Posted Date
- 2013-09-12
- Last Posted Date
- 2013-09-12
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT01940731
- Locations
- 🇨🇳
The Seond Hospital of Jilin University, Jilin, China
🇨🇳Huashan Hospital ,Fudan University, Shanghai, China
🇨🇳Shanghai Pulmonary Hospital, Shanghai, China
A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
- First Posted Date
- 2013-09-10
- Last Posted Date
- 2013-09-10
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 540
- Registration Number
- NCT01937832
- Locations
- 🇨🇳
The Second Hospital of Jilin University, Changchun, Jilin, China
🇨🇳The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Anhui Provincial Hospital, Hefei, Anhui, China
Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B
- Conditions
- Interventions
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2017-12-29
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 287
- Registration Number
- NCT01926288
- Locations
- 🇨🇳
Beijing You An Hospital,Capital Medical University, Beijing, Beijing, China
🇨🇳Tongji Medical College of Hust Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China
🇨🇳The First Affiliated Hospital Of Nanjing Medical University, Nanjing, Jiangsu, China
Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）
- Conditions
- Interventions
- First Posted Date
- 2013-08-16
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 117
- Registration Number
- NCT01924195
- Locations
- 🇨🇳
Hunan Province Tumor Hospital, Changsha, Hunan, China
🇨🇳Shanghai Changhai Hospital, Shanghai, Shanghai, China
🇨🇳Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
- Conditions
- Interventions
- First Posted Date
- 2013-06-25
- Last Posted Date
- 2013-06-25
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 189
- Registration Number
- NCT01886053
- Locations
- 🇨🇳
Anhui Provincial Hospital, Hefei, Anhui, China
🇨🇳First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Sun Yat-sen Memorial Hospital Sun Yat-sen University, Guangzhou, Guangdong, China
A Phase II Study of Anlotinib in STS Patients
- First Posted Date
- 2013-06-17
- Last Posted Date
- 2019-05-22
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 166
- Registration Number
- NCT01878448
- Locations
- 🇨🇳
Chinese PLA General Hospital, Beijing, Beijing, China
🇨🇳Beijing Jishuitan Hospital, Beijing, Beijing, China
🇨🇳Fujian Province Cancer Hospital, Fuzhou, Fujian, China
A Phase II Study of Anlotinib in MTC Patients
- First Posted Date
- 2013-06-11
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 58
- Registration Number
- NCT01874873
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳The first hospital affiliated to fujian medical university, Fuzhou, Fujian, China
🇨🇳Gansu Province Tumor Hospital, Lanzhou, Gansu, China
A Bioequivalence Study of Capecitabine Tablets
- Conditions
- Interventions
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2013-10-01
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT01846650
- Locations
- 🇨🇳
First Affiliated Hospital of Fourth Military Medical University, Xi an, Shanxi, China
A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics
- First Posted Date
- 2013-04-17
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 35
- Registration Number
- NCT01833923
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China